Ambu has replaced its duodenoscopes the world over: "We have the product of choice"

Following a clinical study with 29 people, medtech company Ambu has already replaced its duodenoscopes on the global market. The company's CEO, Juan Jose Gonzalez, is sure the new version will beat competitors and become the preferred choice.
Juan Jose Gonzalez, CEO at Ambu, is very encouraged by the results of a study with the company's newest version of its duodenoscope. The products have thus already been replaced globally. | Photo: Ambu/PR
Juan Jose Gonzalez, CEO at Ambu, is very encouraged by the results of a study with the company's newest version of its duodenoscope. The products have thus already been replaced globally. | Photo: Ambu/PR
BY ULRICH QUISTGAARD, TRANSLATED BY DANIEL PEDERSEN

In connection with Ambu's newly released full-year financial report, the company has announced updating its duodenoscopes to a new version called Ascope Duodeno 1.5 for use in duodenoscopy procedures. Ambu CEO Juan Jose Gonazalez confirms to MedWatch that the product transition was initiated before the announcement.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading